Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Sell
103,574
-16,936
-14% -$451K 0.25% 86
2025
Q4
$3M Sell
120,510
-12,316
-9% -$311K 0.25% 81
2025
Q3
$3.38M Sell
132,826
-3,547
-3% -$87.5K 0.3% 80
2025
Q2
$3.31M Buy
136,373
+11,658
+9% +$272K 0.31% 81
2025
Q1
$3.16M Buy
124,715
+7,046
+6% +$184K 0.32% 78
2024
Q4
$3.12M Buy
117,669
+31,479
+37% +$854K 0.31% 79
2024
Q3
$2.49M Sell
86,190
-7,426
-8% -$217K 0.25% 91
2024
Q2
$2.62M Sell
93,616
-7,466
-7% -$206K 0.28% 80
2024
Q1
$2.81M Sell
101,082
-4,840
-5% -$134K 0.31% 79
2023
Q4
$3.05M Sell
105,922
-110,301
-51% -$3.33M 0.36% 70
2023
Q3
$7.17M Sell
216,223
-17,634
-8% -$624K 0.92% 33
2023
Q2
$8.58M Sell
233,857
-7,648
-3% -$298K 1.05% 27
2023
Q1
$9.85M Sell
241,505
-7,603
-3% -$328K 1.28% 20
2022
Q4
$12.8M Sell
249,108
-6,969
-3% -$334K 1.7% 13
2022
Q3
$12.1M Sell
256,077
-726
-0.3% -$35.3K 1.57% 16
2022
Q2
$12.4M Sell
256,803
-3,378
-1% -$172K 1.55% 18
2022
Q1
$12.9M Buy
260,181
+6,814
+3% +$354K 1.7% 15
2021
Q4
$15M Sell
253,367
-1,107
-0.4% -$54.8K 1.66% 16
2021
Q3
$11.1M Buy
254,474
+1,459
+0.6% +$64.6K 1.26% 22
2021
Q2
$11.4M Buy
253,015
+1,383
+0.5% +$53.8K 1.32% 22
2021
Q1
$9.73M Buy
251,632
+2,938
+1% +$104K 1.18% 24
2020
Q4
$8.56M Sell
248,694
-8,301
-3% -$304K 1.13% 26
2020
Q3
$8.95M Sell
256,995
-1,020
-0.4% -$35.8K 1.35% 22
2020
Q2
$8.01M Buy
258,015
+5,072
+2% +$172K 1.34% 22
2020
Q1
$7.83M Buy
252,943
+14,386
+6% +$490K 1.54% 20
2019
Q4
$8.87M Buy
238,557
+20,239
+9% +$721K 1.41% 20
2019
Q3
$7.44M Buy
218,318
+10,986
+5% +$399K 1.3% 22
2019
Q2
$8.52M Buy
207,332
+6,009
+3% +$239K 1.53% 19
2019
Q1
$8.11M Buy
201,323
+2,197
+1% +$88K 1.51% 20
2018
Q4
$8.25M Buy
199,126
+6,623
+3% +$275K 1.7% 16
2018
Q3
$8.05M Buy
192,503
+1,543
+0.8% +$59.4K 1.58% 18
2018
Q2
$6.57M Buy
190,960
+340
+0.2% +$11.6K 1.39% 21
2018
Q1
$6.42M Buy
190,620
+9,201
+5% +$316K 1.39% 22
2017
Q4
$6.23M Sell
181,419
-2,563
-1% -$87.4K 1.33% 24
2017
Q3
$6.23M Buy
183,982
+6,306
+4% +$203K 1.4% 20
2017
Q2
$5.66M Buy
177,676
+3,924
+2% +$124K 1.31% 25
2017
Q1
$5.64M Buy
173,752
+22,998
+15% +$725K 1.34% 23
2016
Q4
$4.65M Buy
150,754
+5,134
+4% +$157K 1.2% 27
2016
Q3
$4.68M Buy
145,620
+613
+0.4% +$20.5K 1.27% 24
2016
Q2
$4.84M Sell
145,007
-2,987
-2% -$95.3K 1.35% 22
2016
Q1
$4.16M Sell
147,994
-3,554
-2% -$102K 1.21% 27
2015
Q4
$4.64M Buy
151,548
+6,369
+4% +$200K 1.38% 23
2015
Q3
$4.33M Buy
145,179
+9,200
+7% +$295K 1.44% 16
2015
Q2
$4.33M Buy
+135,979
New +$4.43M 1.36% 20

Other funds holding PFE

Fiduciary Group's PFE Position: Q1 2026 in Review

Fiduciary Group reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $451K and leaving 103,574 shares worth $2.91M. The position accounts for 0.25% of the portfolio, ranked #86.

Fiduciary Group first reported a position in PFE in Q2 2015 and has held it in 44 quarters since. The position peaked at $15M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fiduciary Group held 103,574 shares of Pfizer worth $2.91M as of Q1 2026.
  • Fiduciary Group sold 16,936 Pfizer shares in Q1 2026, an estimated $451K.
  • Pfizer made up 0.25% of Fiduciary Group's portfolio in Q1 2026, its #86 holding.
  • Fiduciary Group first reported a position in Pfizer in Q2 2015 and has held it in 44 quarters since.
  • Fiduciary Group's Pfizer position peaked at $15M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.